These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28099635)

  • 21. Evaluation of a vancomycin dosing protocol for intensive care unit patients.
    Brinkman I; Verstappen G; Veeger N; Boerma EC; Buter H
    Neth J Med; 2015 May; 73(4):195-8. PubMed ID: 25968297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining steady-state trough range in vancomycin drug dosing using machine learning.
    Tootooni MS; Barreto EF; Wutthisirisart P; Kashani KB; Pasupathy KS
    J Crit Care; 2024 Aug; 82():154784. PubMed ID: 38503008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
    Wei WX; Qin XL; Cheng DH; Lu H; Liu TT
    J Clin Pharm Ther; 2016 Dec; 41(6):650-656. PubMed ID: 27578443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
    de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
    PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients.
    Pan Y; He X; Yao X; Yang X; Wang F; Ding X; Wang W
    BMC Infect Dis; 2020 May; 20(1):341. PubMed ID: 32404057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
    Reilly AM; Ding MX; Rower JE; Kiser TH
    J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
    Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
    J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.
    Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE
    Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?
    Pires FR; Paula SI; Delgado AF; Carvalho WB; Duarte NJC; Morales Júnior R; Santos SRCJ
    Rev Bras Ter Intensiva; 2020; 32(3):391-397. PubMed ID: 33053028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ; De Bacquer D; De Vriese AS
    Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
    Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
    Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
    Huang M; Wu H; Zhou J; Xu M; Zhou S
    Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.